Fernando E. Membreno

973 citations
14 papers · 721 · 1 hit paper · h-index 8

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Liver Disease Diagnosis and Treatment 8
    • Hepatitis B Virus Studies 7
    • Hepatitis C virus research 8
    • Liver Disease and Transplantation 3

Fernando E. Membreno

14 papers receiving 699 citations

Fernando E. Membreno's Hit Papers

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial 2013 · 438 citations
4380+4+8Years since publication100200300400

Peers

Fernando E. Membreno
Comparison fields: 5 of 55
  • Hepatology 627
  • Epidemiology 599
  • Infectious Diseases 126
  • Transplantation 9
  • Rheumatology 39
Replace Kerstin Port with:
Kerstin Port Germany
R. Ghalib United States
Riina Salupere Estonia
V. Carreño Spain
Maissa El Raziky Egypt
C.-L. Jen Taiwan
Natarajan Ravendhran United States
Hiromitsu Kumada Japan
O. Chazouillères France
D. Hueppe Germany
Fernando E. Membreno relative to Kerstin Port Germany Kerstin Port's profile →
Citations per field
00.5×1.5×1.8×
Kerstin Port · 1×
Citations per year

Countries citing papers authored by Fernando E. Membreno

Since Specialization
Citations

This map shows the geographic impact of Fernando E. Membreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando E. Membreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando E. Membreno more than expected).

Fields of papers citing papers by Fernando E. Membreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando E. Membreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando E. Membreno. The network helps show where Fernando E. Membreno may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando E. Membreno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando E. Membreno Line = papers co-authored together Fernando E. Membreno links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Hit paper breakdown →
2013438
2 201490
3 202362
4 201141
5 200532
6 201221
7 201412
8 200810
9 20045
10 20053
11 20032
12 20122
13 20202
14 20081

About Fernando E. Membreno

Fernando E. Membreno is a scholar working on Epidemiology, Hepatology, Surgery, Infectious Diseases and Molecular Biology, having authored 14 papers that have together received 721 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (7 papers), Liver Disease and Transplantation (3 papers), Organ Transplantation Techniques and Outcomes (2 papers), Signaling Pathways in Disease (1 paper), Blood disorders and treatments (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hepatology (627 citations), Epidemiology (599 citations), Infectious Diseases (126 citations), Transplantation (9 citations) and Rheumatology (39 citations). Fernando E. Membreno has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Eric Lawitz, John G. McHutchison, Robert H. Hyland, William T. Symonds, Fred Poordad, Hongmei Mo, Phillip S. Pang, Xiao Ding, Diana M. Brainard and Daryl Lau. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Clinics in Liver Disease, Hepatology, Gastrointestinal Endoscopy and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact